On October 12, 2023, a curated group of 30+ experienced investors will assemble to dissect the future of investment in the biotech, healthcare, and pharmaceutical realms. They will also delve into hot topics like gene editing, AI in drug discovery, and personalized medicine, as well as the trends projected to gain traction in the coming 2024 year. In addition to analyzing the latest biotechnological innovations with transformative potential, the event will shed light on the often-complicated terrain of securing capital for startups in this dynamic and complex sector.
The 146th PIFW: “From Lab to Market, Capitalizing on Biotech Breakthroughs in 2023” is a select assembly designed to offer attendees a rare chance to glean insights from industry leaders. Participants will also discover investment approaches for both early-stage and scaling companies in healthcare and biotech, with a particular focus on the challenges and solutions for capital raising in the modern biotech environment.